Ravikanth Kona

Ravikanth Kona

National Center for Toxicological Research - - / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4851431
-
person_outline Ravikanth Kona's MOST POPULAR ARTICLES
1-) Quality by design I: application of failure mode effect analysis (FMEA) and Plackett–Burman design of experiments in the identification of “main factors” in the formulation and …R Fahmy, R Kona, R Dandu, W Xie, G Claycamp, SW HoagAAPS pharmscitech 13 (4), 1243-1254, 20121192012
2-) Application of in-line near infrared spectroscopy and multivariate batch modeling for process monitoring in fluid bed granulationR Kona, H Qu, R Mattes, B Jancsik, RM Fahmy, SW HoagInternational journal of pharmaceutics 452 (1-2), 63-72, 2013692013
3-) United States Food and Drug Administration and Department of Defense Shelf‐Life Extension Program of Pharmaceutical Products: Progress and PromiseSR Khan, R Kona, PJ Faustino, A Gupta, JS Taylor, DA Porter, M KhanJournal of Pharmaceutical Sciences 103 (5), 1331-1336, 2014242014
4-) Monitoring transport across modified nanoporous alumina membranesSS Penumetcha, R Kona, JL Hardin, AL Molder, ED SteinleSensors 7 (11), 2942-2952, 2007222007
5-) Quality-by-design II: application of quantitative risk analysis to the formulation of ciprofloxacin tabletsHG Claycamp, R Kona, R Fahmy, SW HoagAAPS PharmSciTech 17, 233-244, 2016212016